Skip to main content
letter
. 2021 Jun 15;76(6):1943–1944. doi: 10.1111/all.14761

FIGURE 1.

FIGURE 1

Active components and excipients listed in BNT162b2, mRNA‐1273, and AZD1222 vaccines. The principles of the PEGylated‐lipid nanoparticles as a delivery system for the mRNA in BNT162b2, mRNA‐1273 vaccines are depicted in the upper part together to the replication‐deficient adenovirus ChAdOx1 vector containing the gene of the glycoprotein spike (S) antigen of SARS‐CoV‐2 for the AZD1222 vaccine. Potential triggers of allergic reactions are indicated in red color in the excipient lists of each vaccine